EMILY GLOSSOP: Open Payments
NPI 1588295422 · DESTIN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,856 in 75 payments from 25 companies in 2025. Trend: 2023 $1,449 · 2024 $1,945 · 2025 $2,856
Food & beverage: $1,837Travel & lodging: $1,018
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 20 | $1,577 |
| BETA BIONICS, INC. | 5 | $115 |
| Lilly USA, LLC | 5 | $107 |
| Radius Health, Inc. | 1 | $107 |
| Xeris Pharmaceuticals, Inc. | 5 | $104 |
| Tandem Diabetes Care, Inc. | 3 | $89 |
| Amgen Inc. | 4 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $82 |
| IBSA Pharma Inc. | 4 | $77 |
| Ascendis Pharma Endocrinology Inc | 3 | $60 |
Products named: MINIMED 780G, iLet Bionic Pancreas, Tymlos, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, Kerendia, Tirosint, GVOKE HYPOPEN.
Industry payments across FL — which companies pay providers there.
